Crescendo Bioscience To Feature New Data On Vectra DA At 2014 ACR Meeting
November 10, 2014 at 07:43 AM EST
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (Nasdaq: MYGN), today announced that new data on Vectra® DA ...